
BlackRock Health Sciences Opportunities Portfolio Institutional Shares
SHSSX
Updated: 23/09/2026, 17:05:49
This portfolio primarily directs its capital, dedicating a minimum of 80% of its total assets, towards equity holdings—chiefly common shares—of companies operating within the health sciences and closely related sectors. This comprehensive category includes businesses involved in medical equipment and supplies, healthcare service provision, biotechnology, and pharmaceutical research and manufacturing. The fund maintains a focused investment approach, ensuring that more than a quarter (over 25%) of its assets are committed to these health sciences industries. Additionally, it has the flexibility to include investments in companies based outside of the United States.
No summaries found.
- Share price
- $71.46
- Market cap
- $6.58B
- Exchange
- NASDAQ
- Currency
- USD
- CEO
- N/A
- Employees
- N/A
- IPO date
- 16/10/2000
- Beta
- 0.516
- Last dividend
- $0.00
- Day range
- $71.46 – $71.46
- 52-week range
- $63.65 – $76.03
- 1-day performance
- 0.76%
- 1-year performance
- 12.27%
- Current drawdown (1Y)
- -6.01%
- CIK
- 0000844779
- CUSIP
- 091937540
- ISIN
- US0919375404
- Created
- 07/12/2025, 14:13:25
- Last update
- 23/09/2026, 17:05:49
Track BlackRock Health Sciences Opportunities Portfolio Institutional Shares with an AI analyst
See which prediction-market events move SHSSX, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
No news found for this symbol.